Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06258447 · ClinicalTrials.gov registry record · NA
CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction
A NA study of Ischemic Heart Failure, sponsored by BioCardia.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 5
- Study locations
NCT06258447 is a NA study of Ischemic Heart Failure that is actively recruiting participants, run by BioCardia. The registered enrollment target is 250 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT06258447, a NA study of Ischemic Heart Failure, is actively recruiting participants, sponsored by BioCardia.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 5
- Study locations
Study Summary
Concentrated autologous bone marrow mononuclear cells (ABM MNC) contain potentially therapeutic cell factors and past studies support therapeutic benefit to patients with cardiac diseases of acute myocardial infarction, ischemia, and heart failure when utilized as this study is designed. The purpose of the study is to determine the safety and efficacy of CardiAMP cell therapy system in patients with ischemic heart failure. It is a prospective, multi-center, randomized, controlled, patient and evaluator-blinded study comparing treatment with the CardiAMP cell therapy system to a control procedure with diagnostic catheterization.
Conditions Studied
Interventions
- DEVICE Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system
Study Locations (5)
Florida
- Morton Plant Hospital - BayCare - Clearwater
Georgia
- Emory University - Atlanta
Michigan
- Henry Ford Hospital - Detroit
Ohio
- Cleveland Clinic - Cleveland
Wisconsin
- University of Wisconsin-Division of Cardiovascular Medicine - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2029-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06258447
The ClinicalTrials.gov registry entry for NCT06258447 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioCardia, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ischemic Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system is the first listed.
NCT06258447 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Georgia, Michigan.
Frequently Asked Questions
What is clinical trial NCT06258447 about?
NCT06258447 is a clinical study titled "CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction". Concentrated autologous bone marrow mononuclear cells (ABM MNC) contain potentially therapeutic cell factors and past studies support therapeutic benefit to patients with cardiac diseases of acute myocardial infarction, ischemia, and heart failure when utilized as this study is designed. The purpose...
What is the current status of trial NCT06258447?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-08-01. Estimated completion is 2029-04-01.
What conditions does trial NCT06258447 study?
This clinical trial studies the following conditions: Ischemic Heart Failure.
What interventions are being tested in trial NCT06258447?
The interventions under investigation include: Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system (DEVICE).
Who is sponsoring clinical trial NCT06258447?
This trial is sponsored by BioCardia, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06258447 being conducted?
This trial has 5 study locations across Florida, Georgia, Michigan, Ohio, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.